Delivery Order SPE2DB22D3011-SPE2DB24FP8UN
Award Date 1/25/24
Potential Completion Date 1/26/24
Potential Value $7.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets. The contract has a completion date of January 30, 2024 and a potential value of $6,528.94. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. This IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,668.97 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to support the Department of...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets. The contract has a potential value of $1,664.49 and a period of performance through February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order is issued under a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $1,734.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 8 mg tablets. The contract has a completion date of January 26, 2024 and was awarded on January 25, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order (DO) contract valued at $1,878.06 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Ondansetron ODT 4 mg tablets. This DO is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between DLA and Amerisourcebergen, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Ondansetron ODT 4 mg tablets. The contract has a completion date of February 26, 2024 and a potential value of $2,571.12. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) with DLA, valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Ondansetron ODT 4 mg tablets. The order, valued at $3,672.70, has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,496,328 ondansetron ODT 4 mg tablets. The contract has a potential value of $25,005.60 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp serves as the prime contractor, providing pharmaceutical products and medical supplies to the Department of Defense through an indefinite delivery...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,874.12 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,144,293 units of Ondansetron ODT 4 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,831.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of Ondansetron ODT 4 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 with a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and...